New diabetes clinical trial: INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Published on: November 03, 2025 at 11:00PM
Conditions: Type 1 Diabetes Mellitus
Interventions: Drug: Technosphere Insulin; Drug: Technosphere Insulin; Drug: Basal insulin
Sponsors: Mannkind Corporation; Jaeb Center for Health Research
Not yet recruiting
https://ift.tt/497KNeU
Conditions: Type 1 Diabetes Mellitus
Interventions: Drug: Technosphere Insulin; Drug: Technosphere Insulin; Drug: Basal insulin
Sponsors: Mannkind Corporation; Jaeb Center for Health Research
Not yet recruiting
https://ift.tt/497KNeU
Comments
Post a Comment